THE THROMBOSIS RESEARCH INSTITUTE
Research has continue to focus on three broad ares: venous thromboembolic disease, atherothrombosis and cancer associated thrombosis. Educational symposia bring together researchers and practising clinicians to disseminate the results of research.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a surplus of £228,748 for the year ended 31 July 2025, with total unrestricted reserves of £7,409,920. The Trustees consider the financial health of the Institute to be good, noting that unrestricted annual expenditure was £3.22m and that the charity continues to attract funds to support its research and educational activities.
What the accounts disclose
“In the band £200,000 - £210,000 1” — page 31
“Income from charitable activities - Research 2,382,840” — page 27
“The Institute is engaged in carrying out scientific research which requires it to maintain a ‘state of the art’ research facility and for which the Trustees consider it prudent to maintain reserves where possible of not less than one year’s running expenses.” — page 10
“The Institute is connected with the Thrombosis Research Trust (a charitable trust that is a registered charity number 275275) as it has the object of promoting and funding research into the prevention and treatment of thrombosis disease, which it fulfils by supporting the Institute. At the year-end, Mr Patrick Burgess was a Trustee of the Institute and the Thrombosis Research Trust.” — page 5
“The investments in group undertakings consist of shares and loans in the institute’s subsidiary undertakings as follows: TRI Technology Transfer Limited (intellectual property) TRI Clinical Trials Limited (Research and intellectual property)” — page 33
Year-over-year changes
- Top pay band moved from £190,001 - £200,000 (FY2024) to £200,001 - £210,000 (FY2025).
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/07/2025)
Trustees
- PATRICK BURGESS MBEchair
- GUY HOWARD WESTON
- LORD DAVID NEUBERGER
- Revd Dr Sir Ralph Waller
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £3.4m | £3.2m |
| 31/07/2024 | £3.1m | £2.9m |
| 31/07/2023 | £1.7m | £3.2m |
| 31/07/2022 | £3.5m | £4.4m |
| 31/07/2021 | £3.3m | £6.9m |
Common questions
Is THE THROMBOSIS RESEARCH INSTITUTE financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a surplus of £228,748 for the year ended 31 July 2025, with total unrestricted reserves of £7,409,920. The Trustees consider the financial health of the Institute to be good, noting that unrestricted annual expenditure was £3.22m and that the charity continues to attract funds to support its research and educational activities. Its FY2025 accounts were audited by HaysMac LLP.
What does the highest-paid employee of THE THROMBOSIS RESEARCH INSTITUTE earn?
Per its FY2025 accounts, the highest-paid employee was in the £200,001 - £210,000 band.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE JOHN HEMINGWAY CHARITABLE TRUST | 1 | £10k |
| MATTHEW GOOD FOUNDATION | 1 | £2k |
| THE KNOLL CHARITABLE TRUST | 1 | £250 |
Charities like this
- THROMBOSIS UK
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- PSYCHIATRY RESEARCH TRUST
- PTEN RESEARCH FOUNDATION
- THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK)
- HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE THROMBOSIS RESEARCH INSTITUTE | £3.4m | £200,001 - £210,000 | — | above | — | no doubt |
| THROMBOSIS UK | £293k | — | 0 | unclear | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |
| PSYCHIATRY RESEARCH TRUST | £388k | — | 0 | unclear | — | no doubt |
| PTEN RESEARCH FOUNDATION | £716k | £180,001 - £190,000 | — | unclear | — | no doubt |
| THE GEORGE INSTITUTE FOR GLOBAL HEALTH (UK) | £2.9m | — | — | unclear | — | no doubt |